KRAS and TP53 mutations are correlated with lower survival rate in resected pancreatic ductal adenocarcinoma. (2019) - Masetti, M.; de Biase, D.; Lombardi, R.; Tumiati, D.; Acquaviva, G.; di Giacomo, S.; Fornelli, A.; Jovine, E.